November 4, 2025 — Leads & Copy —
Hinge Health, Inc. (NYSE: HNGE) reported its Q3 2025 financial results, showcasing robust growth. Revenue increased 53% year-over-year to $154.2 million. The company surpassed 1.5 million lifetime members and generated record free cash flow.
GAAP gross margin reached 82%, and non-GAAP gross margin was 83%. Net cash from operating activities totaled $82.4 million, and free cash flow was $81.3 million. As of September 30, 2025, cash, cash equivalents, and marketable securities amounted to $496.9 million.
Looking ahead, Hinge Health anticipates Q4 2025 revenue between $155 million and $157 million, with non-GAAP income from operations between $34 million and $36 million. For fiscal year 2025, revenue guidance is increased to $572 million – $574 million, and non-GAAP income from operations is projected between $106 million and $108 million.
Daniel Perez, Co-Founder and CEO of Hinge Health, emphasized the urgency of automating care delivery amid rising healthcare costs.
Investor Relations
ir.hingehealth.com/events-presentations
Source: Hinge Health, Inc.
